skip to main content
Idioma:
Refinado por: assunto: Male remover assunto: Middle Aged remover assunto: Radiotherapy remover assunto: Adult remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study

Roach, Mack ; Winter, Kathryn ; Michalski, Jeffrey M. ; Cox, James D. ; Purdy, James A. ; Bosch, Walter ; Lin, Xiao ; Shipley, William S.

International journal of radiation oncology, biology, physics, 2004-12, Vol.60 (5), p.1351-1356 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era

Kuban, Deborah A ; Thames, Howard D ; Levy, Larry B ; Horwitz, Eric M ; Kupelian, Patrick A ; Martinez, Alvaro A ; Michalski, Jeff M ; Pisansky, Thomas M ; Sandler, Howard M ; Shipley, William U ; Zelefsky, Michael J ; Zietman, Anthony L

International journal of radiation oncology, biology, physics, 2003-11, Vol.57 (4), p.915-928 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Failure definition–dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?
Failure definition–dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Failure definition–dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?

Kuban, Deborah ; Thames, Howard ; Levy, Larry ; Horwitz, Eric ; Kupelian, Patrick ; Martinez, Alvaro ; Michalski, Jeff ; Pisansky, Thomas ; Sandler, Howard ; Shipley, William ; Zelefsky, Michael ; Zietman, Anthony

International journal of radiation oncology, biology, physics, 2005-02, Vol.61 (2), p.409-414 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: Radiation Therapy Oncology Group Trial 98-03
Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: Radiation Therapy Oncology Group Trial 98-03
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: Radiation Therapy Oncology Group Trial 98-03

Tsien, Christina, M.D ; Moughan, Jennifer, M.S ; Michalski, Jeff M., M.D., M.B.A ; Gilbert, Mark R., M.D ; Purdy, James, Ph.D ; Simpson, Joseph, M.D., Ph.D ; Kresel, John J., M.D., Ph.D ; Curran, Walter J., M.D ; Diaz, Aidnag, M.D ; Mehta, Minesh P., M.D

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (3), p.699-708 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

Rosenthal, Seth A., MD ; Hunt, Daniel, PhD ; Sartor, A. Oliver, MD ; Pienta, Kenneth J., MD ; Gomella, Leonard, MD ; Grignon, David, MD ; Rajan, Raghu, MD ; Kerlin, Kevin J., MD ; Jones, Christopher U., MD ; Dobelbower, Michael, MD ; Shipley, William U., MD ; Zeitzer, Kenneth, MD ; Hamstra, Daniel A., MD, PhD ; Donavanik, Viroon, MD ; Rotman, Marvin, MD ; Hartford, Alan C., MD ; Michalski, Jeffrey, MD ; Seider, Michael, MD ; Kim, Harold, MD ; Kuban, Deborah A., MD ; Moughan, Jennifer, MS ; Sandler, Howard, MD

International journal of radiation oncology, biology, physics, 2015-10, Vol.93 (2), p.294-302 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Predictive Factors for Late Genitourinary and Gastrointestinal Toxicity in Patients With Prostate Cancer Treated With Adjuvant or Salvage Radiotherapy
Predictive Factors for Late Genitourinary and Gastrointestinal Toxicity in Patients With Prostate Cancer Treated With Adjuvant or Salvage Radiotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predictive Factors for Late Genitourinary and Gastrointestinal Toxicity in Patients With Prostate Cancer Treated With Adjuvant or Salvage Radiotherapy

Feng, Mary, M.D ; Hanlon, Alexandra L., Ph.D ; Pisansky, Thomas M., M.D ; Kuban, Deborah, M.D ; Catton, Charles N., M.D ; Michalski, Jeff M., M.D ; Zelefsky, Michael J., M.D ; Kupelian, Patrick A., M.D ; Pollack, Alan, M.D., Ph.D ; Kestin, Larry L., M.D ; Valicenti, Richard K., M.D., M.A ; DeWeese, Theodore L., M.D ; Sandler, Howard M., M.D

International journal of radiation oncology, biology, physics, 2007-08, Vol.68 (5), p.1417-1423 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02

Rosenthal, Seth A., M.D ; Bae, Kyoungwha, Ph.D ; Pienta, Kenneth J., M.D ; Sobczak, Mark L., M.D ; Asbell, Sucha O., M.D ; Rajan, Raghu, M.D ; Kerlin, Kevin J., M.D ; Michalski, Jeff M., M.D ; Sandler, Howard M., M.D

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (3), p.672-678 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2003  (1)
  2. 2003Até2003  (1)
  3. 2004Até2004  (1)
  4. 2005Até2007  (2)
  5. Após 2007  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.